Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

BACKGROUND: In spring 2020, at the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Europe, we set up an assay system for large-scale testing of virus-specific and neutralising antibodies including their longevity. METHODS: We analysed the sera of 1655 adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Angelika, Guzek, Angela, Ruff, Johanna, Jasinska, Joanna, Scheikl, Ute, Zwazl, Ines, Kundi, Michael, Stockinger, Hannes, Farcet, Maria R., Kreil, Thomas R., Hoeltl, Eva, Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037317/
https://www.ncbi.nlm.nih.gov/pubmed/35602189
http://dx.doi.org/10.1038/s43856-021-00012-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037317/
https://www.ncbi.nlm.nih.gov/pubmed/35602189
http://dx.doi.org/10.1038/s43856-021-00012-4

Ejemplares similares